BackAngiodynamic Overview
Angiodynamic Inc

Angiodynamic Target Price

Analysts' average 12-month price target for Angiodynamic is $19.

Get informed when a big investor buys or sells

+ Follow

Share Price

$12.02

Average Target Price

$19.0058.1% upside

3 analysts in the last 4 months

High: $20 | Low: $18

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-10-13H.C. WainwrightYi Chen$1849.8% upsideOpen
2026-07-15H.C. WainwrightYi Chen$1958.1% upsideOpen
2026-07-15Canaccord Genuity$2066.4% upsideOpen
2025-10-03Canaccord Genuity$1849.8% upsideOpen
2025-07-16Canaccord GenuityJohn Young$1741.4% upsideOpen
2024-10-04Canaccord GenuityWilliam Plovanic$120.2% downsideOpen
2024-09-20H.C. WainwrightYi Chen$1416.5% upsideOpen
2024-04-05OppenheimerSteven Lichtman$120.2% downsideOpen
2023-01-06Raymond James$2283% upsideOpen
2022-07-13Raymond James$27124.6% upsideOpen

Angiodynamic (ANGO) FAQ

Angiodynamic (ANGO) currently reports a target price of $19. Use the charts on this page to explore Angiodynamic's target price history and peer comparisons.

Analysts' average 12-month price target for Angiodynamic is $19, about 58.1% upside from the current share price of $12.02. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $19, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Angiodynamic, and consider following ANGO for alerts when major investors trade the stock.

Angiodynamic is classified in the Healthcare sector. On target price, it currently shows $19. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ANGO with unrelated industries.